Although it may be said that Infrastrata (LON:INFA) has been something of a Cinderella stock in the recent past, it would appear that the latest developments at the group could signal the start of a lasting turnaround. Apart from the share price drift, there have been a couple of problems associated with the Infrastrata story…
I started out on this series thinking I would ask where investors – private and institutional – will go for good research, given that regulation – particularly Mifid II due to come into force next year – is said to be causing brokers to lay off their analysts. This raises the question: What is good…
There is still no whiff of adverse rumour surrounding Six Hundred Group (LON:SIXH). This makes it a stonking buy at 13p. My reservation is that since it is so obviously cheap there has to be a reason for the share price being down here. ***** I used to regard listening to Any Questions on BBC…
Echo Energy (LON:ECHO), formerly Independent Resources, has already been one of the micro cap stocks of the year to date. It would appear from the daily chart configuration that a new leg to the upside should be with us within days. What was interesting about the break higher for Echo Energy, on news that Sound…
You can tell a political ideology by its tax-and-spend policies. The two far extremes of the English-speaking political world – the new US populist right and the old UK corporatist left – are fashioning very different fiscal programmes. Might Post-Thatcherite Mrs May be the new Middle Way? The wealth of a nation In an interview…
Stretched Valuations Since the beginning of the year, I have been drawing the attention of the reader to the lack of volatility in U.S. markets, as such a high level of complacency is extreme by historical standards and is not supported by current fundamentals. Recently, the VIX (INDEXCBOE:VIX) fell below 10, which is a rare…
Having interviewed the CEO of Challenger Acquisitions (LON:CHAL) a couple of times, and having liked the concept behind the company, it is good to see the first stirrings of recovery for the stock price. I note today on Twitter that some of the traders who normally know what they are doing are backing Challenger Acquisitions…
Investor expectations can be a gift or a curse. Sometimes they allow investors to buy shares at discounted prices because the market expects a difficult period. Other times, however, they can lead to a disappointing share price performance even if a company records high earnings growth. In such a scenario, if profit growth falls below…
It has been a long wait for fans of Silence Therapeutics (LON:SLN) to get a decent rebound in the stock, with the biotechnology group serving up quite a journey ahead of the latest news regarding its intellectual property estate. Having interviewed Silence Therapeutics a number of times, and having become familiar with what it is…
Over the last two of month’s I’ve outlined a series of ten questions which I use to help me avoid yield traps. This month I’m going to interrogate a company using those questions so that you can see them being used in a practical setting. The company in question is KCOM Group (LON:KCOM), a FTSE…
